Kemper (KMPR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Net loss attributable to shareholders was $1.7 million ($0.03 per share) for Q1 2026, down from net income of $99.7 million in Q1 2025, mainly due to higher claim severity/frequency in California personal auto and a $28 million Florida statutory premium refund.
Commercial auto achieved record production, with policies in force up 10% year-over-year and an underlying combined ratio of 92.4%, while the Life segment delivered stable results with $18 million in operating income.
Strategic focus remains on improving profitability, reducing volatility, and diversifying the portfolio, especially away from California, with ongoing restructuring and operational efficiency initiatives targeting over $60 million in run-rate savings.
Investment portfolio delivered solid results, with net investment income rising to $107.1 million, supporting financial flexibility.
Financial highlights
GAAP net loss of $1.7 million ($0.03 per share) for the quarter; adjusted consolidated net operating income was $12.5 million ($0.21 per share), or $34.6 million ($0.59 per share) excluding Florida refunds.
Total revenues for Q1 2026 were $1,107.2 million, a decrease of $85.8 million from Q1 2025, mainly due to lower Specialty Personal Automobile volumes and the Florida refund.
Net investment income increased to $107.1 million, up $5.9 million year-over-year.
Commercial auto written premium exceeded $1 billion on a trailing 12-month basis for the first time.
Trailing twelve-month operating cash flow was $493 million.
Outlook and guidance
Initial benefits from California rate increases expected in Q2 2026, with more meaningful impact in the second half of the year; further rate filings and claims process enhancements are planned.
Ongoing restructuring and efficiency initiatives target a medium-term expense ratio below 20% and continued operational improvements through 2027.
Portfolio diversification and new product rollouts in Florida and Texas are expected to support future growth and reduce earnings volatility.
Latest events from Kemper
- Key votes include director elections, executive pay, and auditor ratification for 2026.KMPR
Proxy filing25 Mar 2026 - Annual meeting features director elections, say-on-pay, auditor ratification, and strong governance.KMPR
Proxy filing25 Mar 2026 - Operational focus, tech investment, and regulatory shifts drive growth and profitability outlook.KMPR
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 net loss of $8m driven by claim severity and refunds; restructuring and new products target recovery.KMPR
Q4 20254 Feb 2026 - Q2 2024 net income reached $75.4M with 11.5% ROE and 4.6% PIF growth, outlook remains strong.KMPR
Q2 20242 Feb 2026 - Q3 2024 net income rebounded to $73.7M, led by Specialty P&C growth and strong capital actions.KMPR
Q3 202417 Jan 2026 - Strong growth and profitability return as rate hikes and market conditions drive expansion.KMPR
Raymond James & Associates’ 46th Annual Institutional Investors Conference 202523 Dec 2025 - Q4 net income more than doubled year-over-year, driven by strong underwriting and capital actions.KMPR
Q4 202420 Dec 2025 - Annual meeting covers director elections, pay, equity plan, and auditor, with strong 2024 results.KMPR
Proxy Filing1 Dec 2025